1434TiP MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma (GEC): Trial in progress
Conference Paper
Full Text
Duke Authors
Cited Authors
- Catenacci, DV; Strickler, JH; Shitara, K; Nakamura, Y; Janjigian, YY; Barzi, A; Bekaii-Saab, T; Lenz, HJ; Chung, HC; Tabernero, J; Yoshino, T; Siena, S; Mayor, JG; Palanca-Wessels, MC; Xie, D; Marshall, JL
Published Date
- September 2021
Published In
Volume / Issue
- 32 /
Start / End Page
- S1071 - S1072
Published By
International Standard Serial Number (ISSN)
- 0923-7534
Digital Object Identifier (DOI)
- 10.1016/j.annonc.2021.08.1543